726Indexed trials
canonical disease area
Depression
Intelligence
Depression intelligence: 726 indexed trials, 136 recruiting studies, 463 sponsors across 70 countries.
136Recruiting
463Sponsors
70Countries
Leading sponsors
University of California, Los Angeles142 recruiting
Massachusetts General Hospital122 recruiting
University of North Carolina, Chapel Hill93 recruiting
Eli Lilly and Company90 recruiting
New York State Psychiatric Institute80 recruiting
Weill Medical College of Cornell University72 recruiting
Yale University72 recruiting
Duke University71 recruiting
Janssen Research & Development, LLC60 recruiting
Johns Hopkins University51 recruiting
Northwestern University50 recruiting
H. Lundbeck A/S50 recruiting
Geographic activity
United States333trials
France49trials
Canada48trials
United Kingdom31trials
China29trials
Germany28trials
Spain23trials
Italy18trials
Turkey (Türkiye)15trials
Denmark14trials
Sweden14trials
Poland12trials
Leading interventions
Escitalopram11trials
Ketamine10trials
Sertraline9trials
Fluoxetine8trials
Duloxetine7trials
Transcranial Magnetic Stimulation7trials
Citalopram6trials
Vortioxetine6trials
Treatment as usual5trials
Olanzapine5trials
Ketamine Hydrochloride4trials
Sham Stimulation4trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.